Patients’ satisfaction with a digital solution aiming for the monitoring and support of patients with immune-mediated rheumatologic diseases
- Conditions
- Rheumatoid arthritis, axial spondyloarthritisMusculoskeletal DiseasesRheumatoid arthritis, unspecified
- Registration Number
- ISRCTN11896540
- Lead Sponsor
- Sociedad Española de Reumatología
- Brief Summary
2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36812651/ (added 06/09/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
1. Over 18 years of age
2. Have a smartphone or tablet-type cell phone
3. Accepting participation in the study and signing the informed consent form
4. Patients under follow-up for at least 1 year in the Complex Therapies Unit of the Rheumatology service with a diagnosis of rheumatoid arthritis, spondyloarthritis, or psoriatic arthritis
1. Not owning a mobile device compatible with the mHealth solution
2. Not being able to participate in the program without assistance
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method